医療機器償還市場：支払者展望、機器タイプ、機器分類、用途、エンドユーザー別-世界予測2025-2030年

医療機器償還市場は、2024年には5,748億米ドルとなり、2025年にはCAGR 7.73%で6,182億5,000万米ドルに成長し、2030年には8,987億8,000万米ドルに達すると予測されています。

急速に進化する今日のヘルスケア環境において、医療機器償還の複雑さを理解することは、戦略立案と事業運営の成功に不可欠です。この包括的な分析では、償還プロセスと医療機器を取り巻く金融エコシステムを形成する重要な要因を掘り下げています。規制の変更、技術革新、支払者のダイナミクスの変化により、償還戦略がどのように影響されるかが明らかにされています。

現在検討されている状況は、先進的な治療や機器の導入によって定義されるだけでなく、コスト効率と質の高いヘルスケアの提供を両立させるという新たな課題によっても定義されます。政策立案者、ヘルスケアプロバイダー、メーカーを含む複数の利害関係者が、意思決定プロセスにおいてより複雑に絡み合うようになり、財務モデルがイノベーションと持続可能性の両方を確実にサポートするようになっています。

本レポートでは、市場促進要因、内在する規制リスク、今後の動向について掘り下げています。現在の市場情報を統合し、主要な市場セグメントが現代の課題にどのように適応しているかについての洞察を提供しています。詳細な分析と将来を見据えた視点を通じて、意思決定者に情報を提供し、力を与えることで、医療機器における複雑な償還力学をナビゲートするための強固な基盤を提供することを目的としています。

市場力学の転換期

この業界は、従来のモデルを再定義し、償還パラダイムの進化のペースを加速させるような、変革的なシフトを目の当たりにしてきました。経済的圧力と急速な技術革新は、償還の状況を変える上で重要な役割を果たすようになってきています。

近年は、量よりも実績と成果を奨励する価値ベースのケアへの移行が見られます。遠隔医療プラットフォームやAIを活用した診断ツールなど、デジタルヘルス技術の統合は、こうした変化をさらに加速させています。これらの進歩により、診療報酬モデルは、固定的なフィー・フォー・サービスの取り決めから、効率性、質の高いアウトカム、患者中心のケアに報いる、より微妙な枠組みへと移行しています。

規制当局もまた、その評価手法を再調整し、臨床効果と長期的なコスト削減をより重視するようになりました。その結果、メーカーは、より厳しいベンチマークを満たし、進化する支払者の期待に沿うよう、製品ポートフォリオを調整しなければならなくなりました。利害関係者がリスクと報酬の共有を約束する革新的な契約形態を模索する中、統合ケアモデルの重視がますます顕著になっています。全体として、このような変革的なシフトは、刻々と変化する情勢の中で成功を収めるためには、俊敏性と先見性のあるアプローチが必要であることを強調しています。

業界動向を牽引する重要なセグメンテーションの洞察

市場セグメンテーションの詳細な評価は、償還戦略に影響を与える無数の要因を理解するために不可欠な青写真を提供します。分析は、市場を民間と公的セグメントに分類する支払者の展望を見ることから始まる。このような二分化により、各支払者に内在する異なる償還基準や経済的期待を理解することが可能となります。

さらに、医療機器のタイプ別に見ると、多面的な構造が明らかになります。消耗品と使い捨て品、画像診断機器、移動補助具、治療機器という切り口で市場を調査しています。消耗品と使い捨て品については、注射器や注射針、創傷ケア製品などの主要品目を詳細に精査しています。画像診断装置はさらに、CTスキャナー、磁気共鳴画像装置、超音波装置、X線装置などに細分化され、これらはまとめて技術革新を示します。治療機器は、透析機器、輸液システム、呼吸療法機器について分析され、後者は酸素療法機器と人工呼吸器に複雑に分けられ、呼吸ケアの重要性が強調されています。

さらに、機器分類に基づくレビューでは、製品をクラスI、クラスII、クラスIIIに分類しています。アプリケーションに基づくセグメンテーションでは、心臓病学、神経学、腫瘍学、整形外科の分野を詳しく見ています。ここで、循環器科はさらに心臓リズム管理機器とインターベンショナル循環器科機器に、神経科は脳脊髄液管理機器と神経刺激機器に、腫瘍科は化学療法管理機器と放射線治療機器に、整形外科は関節再建機器と脊椎手術機器に二分されます。最後に、エンドユーザーについては、外来手術センター、在宅ヘルスケア、病院・クリニックを調査し、後者はさらに入院患者と外来患者に区分しています。このようなセグメンテーションにより、市場促進要因と市場格差を詳細に把握することができます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 専門的な機器を必要とする慢性疾患の増加
    • 政府と民間部門によるヘルスケア費の増加
  • 抑制要因
    • 承認の取得と払い戻し資格の確立に関連する消費者の懸念
  • 機会
    • 遠隔医療とデジタルヘルスソリューションの拡大に伴うコネクテッドデバイスの台頭
  • 課題
    • デバイスの使用と償還の文脈における患者データの保護に関する懸念
• 市場セグメンテーション分析
  • 支払者の展望：広範なアクセスと標準化されたプロセスにおける公的支払者の重要性
  • エンドユーザー：病院やクリニックで医療機器償還を活用し、多様な患者ニーズに対応
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 医療機器償還市場Payer Outlook別

• プライベート
• 公共

第7章 医療機器償還市場：デバイスタイプ別

• 消耗品と使い捨て品
  • 注射器と針
  • 創傷ケア製品
• 診断画像機器
  • コンピュータ断層撮影（CT）スキャナー
  • 磁気共鳴画像（MRI）装置
  • 超音波装置
  • X線システム
• 移動補助具
• 治療機器
  • 透析装置
  • 輸液システム
  • 呼吸療法装置
    • 酸素療法機器
    • 人工呼吸器

第8章 医療機器償還市場デバイス分類別

• クラスI
• クラスII
• クラスIII

第9章 医療機器償還市場：用途別

• 心臓病学
  • 心臓リズム管理
  • インターベンション心臓デバイス
• 神経学
  • 脳脊髄液管理
  • 神経刺激装置
• 腫瘍学
  • 化学療法の投与
  • 放射線治療装置
• 整形外科
  • 関節再建
  • 脊椎手術装置

第10章 医療機器償還市場：エンドユーザー別

• 外来手術センター
• 在宅ヘルスケア
• 病院と診療所
  • 入院ケア
  • 外来診療

第11章 南北アメリカの医療機器償還市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の医療機器償還市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの医療機器償還市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AiM GmbH
• Allianz SE
• Anco Insurance
• Anthem Insurance Companies, Inc.
• Aviva PLC
• BNP Paribas
• CVS Health Corporation
• European Med Tech and IVD Reimbursement Consulting Ltd.
• Hamilton Leigh Ltd.
• HUB International Limited
• Humana Inc.
• MCRA, LLC
• mdiConsultants, Inc.
• Medmarc Insurance Group
• North American Science Associates, Inc.
• Reliance Nippon Life Insurance Company
• UnitedHealth Group
• UnitedHealth Group Incorporated
• WellCare Health Plans, Inc.
• WS Value & Dossier GmbH
• XIFIN, Inc.

LIST OF FIGURES

• FIGURE 1. MEDICAL DEVICES REIMBURSEMENT MARKET MULTI-CURRENCY
• FIGURE 2. MEDICAL DEVICES REIMBURSEMENT MARKET MULTI-LANGUAGE
• FIGURE 3. MEDICAL DEVICES REIMBURSEMENT MARKET RESEARCH PROCESS
• FIGURE 4. MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. MEDICAL DEVICES REIMBURSEMENT MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. MEDICAL DEVICES REIMBURSEMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. MEDICAL DEVICES REIMBURSEMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MEDICAL DEVICES REIMBURSEMENT MARKET DYNAMICS
• TABLE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY SYRINGES & NEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY MOBILITY AIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIALYSIS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY INFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OXYGEN THERAPY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROSTIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CHEMOTHERAPY ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RADIATION THERAPY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY SPINAL SURGERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY IN-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OUT-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 61. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 62. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 64. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 65. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 68. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 70. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 72. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 73. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 74. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 76. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 77. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 78. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 80. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 83. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 85. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 87. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 88. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 90. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 91. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 92. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 94. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 97. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 99. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 101. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 102. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 104. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 105. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 106. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 108. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 111. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 113. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 115. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 116. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 118. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 119. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 120. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 121. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 122. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 125. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 127. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 129. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 130. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 132. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 133. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 136. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 139. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 141. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 143. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 144. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 145. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 147. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 148. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 149. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 150. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 151. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 154. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 156. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 158. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 159. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 160. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 161. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 162. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 163. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 166. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 169. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 171. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 173. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 174. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 175. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 176. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 177. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 179. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 180. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 183. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 185. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 187. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 188. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 190. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 191. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 192. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 193. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 194. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 197. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 199. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 201. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 202. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 203. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 204. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 205. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 206. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 207. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 208. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 210. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 211. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 213. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 215. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 216. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 217. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 218. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 219. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 221. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 222. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 225. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 226. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 227. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 229. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 230. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 231. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 232. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 233. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 234. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 235. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 236. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 239. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 240. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 241. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 242. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 243. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 244. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 245. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 246. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 247. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 248. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 249. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 250. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 252. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 253. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 254. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 255. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 256. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 257. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 258. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 259. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 260. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 261. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 262. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 263. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 264. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 266. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 267. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 268. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 269. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 270. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 271. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 272. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 273. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 274. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 275. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 285. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 286. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 287. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 288. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 289. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 290. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 291. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
• TABLE 292. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 293. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
• TABLE 294. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
• TABLE 295. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 296. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
• TABLE 297. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 298. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
• TABLE 299. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
• TABLE 300. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 301. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 302. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 303. THAILAND MEDICAL DEVICES REIM

The Medical Devices Reimbursement Market was valued at USD 574.80 billion in 2024 and is projected to grow to USD 618.25 billion in 2025, with a CAGR of 7.73%, reaching USD 898.78 billion by 2030.

In today's rapidly evolving healthcare environment, understanding the complexities of medical devices reimbursement is critical for strategic planning and operational success. This comprehensive analysis delves into the critical factors shaping reimbursement processes and the financial ecosystem surrounding medical devices. It highlights how reimbursement strategies are increasingly influenced by regulatory changes, technological innovations, and shifts in payer dynamics.

The landscape under review is not only defined by the introduction of advanced treatments and devices but also by the emerging challenges in aligning cost efficiency with high-quality healthcare delivery. Several stakeholders, including policymakers, healthcare providers, and manufacturers, are now more intertwined in the decision-making process, ensuring that financial models support both innovation and sustainability.

This report provides an in-depth exploration of market drivers, inherent regulatory risks, and future trends. It synthesizes current market intelligence and offers insights into how key market segments are adapting to contemporary challenges. Through detailed analysis and a forward-looking perspective, the discussion aims to inform and empower decision-makers, offering them a robust foundation to navigate the intricate reimbursement dynamics in medical devices.

Transformative Shifts in the Market Dynamics

The industry has witnessed transformative shifts that have redefined traditional models and accelerated the pace at which reimbursement paradigms evolve. Increasingly, economic pressures and rapid technological innovations have played a significant role in altering the reimbursement landscape.

Recent years have seen a migration toward value-based care which encourages performance and outcomes rather than sheer volume. The integration of digital health technologies, including telemedicine platforms and AI-driven diagnostic tools, has further catalyzed these changes. These advancements have transitioned reimbursement models from static fee-for-service arrangements to more nuanced frameworks that reward efficiency, quality outcomes, and patient-centered care.

Regulatory bodies have also recalibrated their assessment methodologies, placing greater emphasis on clinical efficacy and long-term cost savings. As a result, manufacturers have had to tailor their product portfolios to meet stricter benchmarks and to align with evolving payer expectations. Emphasis on integrated care models is increasingly evident, as stakeholders explore innovative contractual arrangements that promise shared risk and reward. Overall, these transformative shifts emphasize the need for agility and a forward-thinking approach in order to thrive amidst an ever-changing landscape.

Critical Segmentation Insights Driving Industry Trends

A detailed evaluation of market segmentation provides an essential blueprint for understanding the myriad factors influencing reimbursement strategies. The analysis begins by looking at payer outlooks which categorizes the market into private and public segments. Such bifurcation makes it possible to appreciate the different reimbursement criteria and financial expectations intrinsic to each payer.

Further, an examination based on device type reveals a multifaceted structure. The market is studied through the lens of consumables and disposables, diagnostic imaging equipment, mobility aids, and therapeutic devices. In-depth scrutiny of consumables and disposables breaks out key items like syringes and needles as well as wound care products. Diagnostic imaging equipment is further subdivided into computed tomography scanners, magnetic resonance imaging equipment, ultrasound devices, and X-ray systems which collectively showcase technological innovations. Therapeutic devices are analyzed by considering dialysis equipment, infusion systems, and respiratory therapy devices; the latter is intricately divided into oxygen therapy equipment and ventilators, emphasizing the critical nature of respiratory care.

Additionally, a review based on device classification segments products into Class I, Class II, and Class III. The application-based segmentation takes a closer look at the areas of cardiology, neurology, oncology, and orthopedics. Here, cardiology is further segmented into cardiac rhythm management and interventional cardiology devices, neurology into cerebrospinal fluid management and neurostimulation devices, oncology into chemotherapy administration and radiation therapy equipment, while orthopedics is bifurcated into joint reconstruction and spinal surgery devices. Finally, when considering end-users, the framework examines ambulatory surgical centers, home healthcare, and hospitals and clinics where the latter is further segmented into in-patient and out-patient care. These segmentation insights afford a granular appreciation of market drivers and disparities.

Based on Payer Outlook, market is studied across Private and Public.

Based on Device Type, market is studied across Consumables and Disposables, Diagnostic Imaging Equipment, Mobility Aids, and Therapeutic Devices. The Consumables and Disposables is further studied across Syringes & Needles and Wound Care Products. The Diagnostic Imaging Equipment is further studied across Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Equipment, Ultrasound Devices, and X-Ray Systems. The Therapeutic Devices is further studied across Dialysis Equipment, Infusion Systems, and Respiratory Therapy Devices. The Respiratory Therapy Devices is further studied across Oxygen Therapy Equipment and Ventilators.

Based on Device Classification, market is studied across Class I, Class II, and Class III.

Based on Application, market is studied across Cardiology, Neurology, Oncology, and Orthopedics. The Cardiology is further studied across Cardiac Rhythm Management and Interventional Cardiology Devices. The Neurology is further studied across Cerebrospinal Fluid Management and Neurostimulation Devices. The Oncology is further studied across Chemotherapy Administration and Radiation Therapy Equipment. The Orthopedics is further studied across Joint Reconstruction and Spinal Surgery Devices.

Based on End-User, market is studied across Ambulatory Surgical Centers, Home Healthcare, and Hospitals & Clinics. The Hospitals & Clinics is further studied across In-patient Care and Out-patient Care.

Regional Dynamics and Growth Opportunities in Global Markets

The global medical devices reimbursement arena is marked by significant regional diversity, which in turn shapes strategic investment and operational priorities. The analysis draws on recent trends observed across major regions. In the Americas, evolving payer models and increasing adoption of advanced technologies have reshaped market dynamics, spurring both innovation and competitive pricing structures.

In the Europe, Middle East & Africa region, a rich blend of regulatory frameworks and diverse economic conditions has resulted in a unique mix of challenges and opportunities. Stakeholders in this region benefit from concerted efforts toward regulatory harmonization coupled with market-driven reforms that foster enhanced interconnectivity between healthcare providers and insurers.

The Asia-Pacific region stands out as a hotbed of growth, marked by rapidly evolving infrastructure, a rising middle class, and increasing healthcare expenditures. This dynamic environment provides fertile ground for both established and emerging players to capitalize on new market segments. The nuanced differences and similarities across these regions underline the importance of a tailored strategic approach to meet localized demands while maintaining a global perspective.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insightful Analysis of Prominent Market Players and Their Strategies

The competitive landscape is defined by a diverse set of companies that bring varying strengths and strategic orientations to the table. Market leaders demonstrate a rich tapestry of innovation, risk management, and flexible service offerings, which redefines success in reimbursement strategies. Established firms such as AiM GmbH and Allianz SE have carved out leadership positions by leveraging their deep market expertise and maintaining a strong commitment to quality. Other major stakeholders including Anco Insurance and Anthem Insurance Companies, Inc. have successfully aligned their strategies with emerging digital trends and regulatory expectations, thereby fortifying their market presence.

Furthermore, companies like Aviva PLC, BNP Paribas, and CVS Health Corporation remain at the forefront of shaping market directions through collaborative initiatives and integrated service models. European Med Tech and IVD Reimbursement Consulting Ltd. and Hamilton Leigh Ltd. are distinguished by their focused approach on bridging clinical innovations with reimbursement realities. HUB International Limited and Humana Inc., along with MCRA, LLC and mdiConsultants, Inc., have expanded their expertise by closely monitoring evolving payer dynamics. Medmarc Insurance Group and North American Science Associates, Inc. further complement this competitive mix with their commitment to leveraging technology and data analytics. Reliance Nippon Life Insurance Company, UnitedHealth Group and its incorporated counterpart, WellCare Health Plans, Inc., WS Value & Dossier GmbH, and XIFIN, Inc. round out a comprehensive competitive overview, reflecting a blend of approaches that are both innovative and responsive to market changes.

The report delves into recent significant developments in the Medical Devices Reimbursement Market, highlighting leading vendors and their innovative profiles. These include AiM GmbH, Allianz SE, Anco Insurance, Anthem Insurance Companies, Inc., Aviva PLC, BNP Paribas, CVS Health Corporation, European Med Tech and IVD Reimbursement Consulting Ltd., Hamilton Leigh Ltd., HUB International Limited, Humana Inc., MCRA, LLC, mdiConsultants, Inc., Medmarc Insurance Group, North American Science Associates, Inc., Reliance Nippon Life Insurance Company, UnitedHealth Group, UnitedHealth Group Incorporated, WellCare Health Plans, Inc., WS Value & Dossier GmbH, and XIFIN, Inc.. Actionable Strategic Recommendations for Market Leaders

For industry leaders navigating the complex reimbursement terrain, actionable strategies are critical to harness the full potential of market opportunities. It is imperative to invest in advanced data analytics and robust forecasting tools to accurately track market shifts and payer behavior. Enhanced collaboration with regulatory bodies can also pave the way for smoother dossier preparation and faster reimbursement cycles. Integrating bespoke digital solutions, particularly in the realm of telehealth and AI-enhanced diagnostic capabilities, can significantly optimize cost management and operational efficiency.

Furthermore, it is advisable to foster cross-functional partnerships that integrate clinical expertise with commercial acumen. Adopting a customer-centric approach by actively engaging with both private and public payers will enable more nuanced pricing strategies that reflect the true value of medical innovations. Emphasis should be placed on continuous staff training to ensure familiarity with emerging trends and regulatory updates. Leaders are encouraged to benchmark against best practices from peer institutions and to remain agile in strategy recalibration, ensuring that product portfolios remain aligned with evolving reimbursement frameworks.

Conclusion: Strategic Pathways for the Future of Medical Device Reimbursement

In summary, the dynamic landscape of medical devices reimbursement demands a multifaceted approach that is both agile and informed by rigorous market analysis. The critical insights drawn from segmentation, regional diversity, and competitive pressures underscore an industry at a crossroads where traditional models are being redefined by innovation and regulatory shifts. Stakeholders today must balance efficiency with effectiveness in order to respond to the increasing complexity of payer demands and technological innovations.

As the market continues to mature, successful navigation will depend on the ability to anticipate trends and create adaptive strategies that align financial outcomes with clinical benefits. This comprehensive summary reinforces the notion that understanding the interplay between policy, technology, and market segmentation is essential. Ultimately, the future will belong to those who can integrate diverse insights into actionable plans, thereby ensuring sustained growth and improved patient outcomes in the medical devices reimbursement arena.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic conditions with need for specialised devices
    • 5.1.1.2. Rising healthcare spending by government and private sectors
  • 5.1.2. Restraints
    • 5.1.2.1. Consumer concerns associated with obtaining approvals and establishing reimbursement eligibility
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise of connected devices with expansion of telemedicine and digital health solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns assocaited with the protection of patient data in the context of device usage and reimbursement
• 5.2. Market Segmentation Analysis
  • 5.2.1. Payer Outlook: Significance of public payer for broad access and standardized processes
  • 5.2.2. End-User: Utilization of medical devices reimbursement in hospitals & clinics to serve diverse patient needs
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Medical Devices Reimbursement Market, by Payer Outlook

• 6.1. Introduction
• 6.2. Private
• 6.3. Public

7. Medical Devices Reimbursement Market, by Device Type

• 7.1. Introduction
• 7.2. Consumables and Disposables
  • 7.2.1. Syringes & Needles
  • 7.2.2. Wound Care Products
• 7.3. Diagnostic Imaging Equipment
  • 7.3.1. Computed Tomography (CT) Scanners
  • 7.3.2. Magnetic Resonance Imaging (MRI) Equipment
  • 7.3.3. Ultrasound Devices
  • 7.3.4. X-Ray Systems
• 7.4. Mobility Aids
• 7.5. Therapeutic Devices
  • 7.5.1. Dialysis Equipment
  • 7.5.2. Infusion Systems
  • 7.5.3. Respiratory Therapy Devices
    • 7.5.3.1. Oxygen Therapy Equipment
    • 7.5.3.2. Ventilators

8. Medical Devices Reimbursement Market, by Device Classification

• 8.1. Introduction
• 8.2. Class I
• 8.3. Class II
• 8.4. Class III

9. Medical Devices Reimbursement Market, by Application

• 9.1. Introduction
• 9.2. Cardiology
  • 9.2.1. Cardiac Rhythm Management
  • 9.2.2. Interventional Cardiology Devices
• 9.3. Neurology
  • 9.3.1. Cerebrospinal Fluid Management
  • 9.3.2. Neurostimulation Devices
• 9.4. Oncology
  • 9.4.1. Chemotherapy Administration
  • 9.4.2. Radiation Therapy Equipment
• 9.5. Orthopedics
  • 9.5.1. Joint Reconstruction
  • 9.5.2. Spinal Surgery Devices

10. Medical Devices Reimbursement Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Home Healthcare
• 10.4. Hospitals & Clinics
  • 10.4.1. In-patient Care
  • 10.4.2. Out-patient Care

11. Americas Medical Devices Reimbursement Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Medical Devices Reimbursement Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Medical Devices Reimbursement Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Inari Medical secures reimbursement for ClotTriever in Japan, partners with Medikit for strategic distribution
  • 14.3.2. UK medical device companies benefit from Medilink and Medical Alley partnership on reimbursement pathways
  • 14.3.3. Medicare's new reimbursement rule enhances market access for FDA breakthrough medical devices
  • 14.3.4. Bipartisan call for CMS to establish a cohesive reimbursement pathway for AI-enabled medical devices
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AiM GmbH
• 2. Allianz SE
• 3. Anco Insurance
• 4. Anthem Insurance Companies, Inc.
• 5. Aviva PLC
• 6. BNP Paribas
• 7. CVS Health Corporation
• 8. European Med Tech and IVD Reimbursement Consulting Ltd.
• 9. Hamilton Leigh Ltd.
• 10. HUB International Limited
• 11. Humana Inc.
• 12. MCRA, LLC
• 13. mdiConsultants, Inc.
• 14. Medmarc Insurance Group
• 15. North American Science Associates, Inc.
• 16. Reliance Nippon Life Insurance Company
• 17. UnitedHealth Group
• 18. UnitedHealth Group Incorporated
• 19. WellCare Health Plans, Inc.
• 20. WS Value & Dossier GmbH
• 21. XIFIN, Inc.